Is Amazon an AI Stock?
With the market starting to look skittish on pure-play AI…
Buy
60
NPCE Quote, Financials, Valuation and Earnings
Last price:
$17.01
Seasonality move
:
72.53%
Day range:
$16.14 - $17.09
52-week range:
$7.56 - $18.98
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
5.70x
P/B ratio:
30.52x
Volume:
223.1K
Avg. volume:
260.2K
1-year change:
51.65%
Market cap:
$565.2M
Revenue:
$79.9M
EPS (TTM):
-$0.75
Analysts' Opinion
-
Consensus RatingNeuroPace, Inc. has received a consensus rating of Buy. The company's average rating is a Buy based on 7 Buy ratings, 0 Hold ratings, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $17.13, NeuroPace, Inc. has an estimated upside of 3.12% from its current price of $16.97.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $13.00 representing 100% downside risk from its current price of $16.97.
Fair Value
-
According to the consensus of 7 analysts, NeuroPace, Inc. has 3.12% upside to fair value with a price target of $17.13 per share.
NPCE vs. S&P 500
-
Over the past 5 trading days, NeuroPace, Inc. has overperformed the S&P 500 by 2.73% suggesting its relative strength compared to the major market average is strong at this time.
Share Buyback
-
NeuroPace, Inc. does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
NeuroPace, Inc. has grown year-over-year revenues for 13 quarters straight. In the most recent quarter NeuroPace, Inc. reported revenues of $27.4M.
Earnings Growth
-
NeuroPace, Inc. has grown year-over-year earnings for 1 quarter straight. In the most recent quarter NeuroPace, Inc. reported earnings per share of -$0.11.
Enterprise value:
576.4M
EV / Invested capital:
6.43x
Price / LTM sales:
5.70x
EV / EBIT:
--
EV / Revenue:
6.08x
PEG ratio (5yr expected):
--
EV / Free cash flow:
-34.76x
Price / Operating cash flow:
--
Enterprise value / EBITDA:
--
Gross Profit (TTM):
$72.8M
Return On Assets:
-23.31%
Net Income Margin (TTM):
-25.29%
Return On Equity:
-149.8%
Return On Invested Capital:
-27.09%
Operating Margin:
-9.51%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Income Statement | ||||||
| Revenue | $60.2M | $76.5M | $94.9M | $21.1M | $27.4M | |
| Gross Profit | $43.4M | $56.4M | $72.8M | $15.4M | $21.2M | |
| Operating Income | -$32M | -$23.1M | -$18.2M | -$4.2M | -$2.6M | |
| EBITDA | -$30M | -$21.3M | -$13.7M | -$3.8M | -$2.1M | |
| Diluted EPS | -$1.50 | -$0.99 | -$0.75 | -$0.19 | -$0.11 | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $140.5M | $104.4M | $84M | $82.6M | $95.3M | |
| Total Assets | $141.3M | $120.5M | $99.3M | $96.3M | $107.3M | |
| Current Liabilities | $8.7M | $9.4M | $12.8M | $14.8M | $19.6M | |
| Total Liabilities | $59.5M | $77.1M | $82.9M | $86.5M | $88.7M | |
| Total Equity | $81.7M | $43.4M | $16.4M | $9.8M | $18.5M | |
| Total Debt | $49.6M | $67.6M | $70.1M | $71.7M | $69.1M | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | -$24.2M | -$16.5M | -$16.3M | -$1.7M | -$1.9M | |
| Cash From Investing | $28.5M | $10.5M | $1.7M | $1.4M | -$30K | |
| Cash From Financing | -$225K | $11.7M | $19.8M | $2.9M | -$235K | |
| Free Cash Flow | -$24.4M | -$16.8M | -$16.6M | -$1.8M | -$2M | |
NPCE
Sector
Market Cap
$565.2M
$28.4M
Price % of 52-Week High
89.43%
50.35%
Dividend Yield
0%
0%
Shareholder Yield
-6.39%
-1.32%
1-Year Price Total Return
51.65%
-22.19%
Beta (5-Year)
--
0.521
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
Technicals
8-day SMA
Buy
Level
$16.39
200-day SMA
Buy
Level
$11.40
Bollinger Bands (100)
Buy
Level
8.5 - 12.88
Chaikin Money Flow
Buy
Level
7M
20-day SMA
Buy
Level
$14.56
Relative Strength Index (RSI14)
Buy
Level
73.00
ADX Line
Buy
Level
40.83
Williams %R
Sell
Level
-2.5532
50-day SMA
Buy
Level
$12.13
MACD (12, 26)
Buy
Level
1.41
25-day Aroon Oscillator
Buy
Level
88
On Balance Volume
Neutral
Level
8M
Financial Scores
Sell
Altman Z-Score
(Annual)
Level (-4.5897)
Sell
CA Score
(Annual)
Level (-2.7659)
Buy
Beneish M-Score
(Annual)
Level (-2.9832)
Buy
Momentum Score
Level (9)
Sell
Ohlson Score
Level (4.4243)
Buy
Piotroski F Score
(Annual)
Level (5)
Buy
Quality Ratio Score
Level (9)
Buy
Fundamental Score
Level (4)
Revenue Forecast
Earnings per Share Forecast
Company Profile
NeuroPace, Inc. develops, manufactures, and markets implantable devices for treating epilepsy and neurological disorders. It offers implantable components, which include the RNS neurostimulator as well as depth and cortical strip leads. The firm's RNS System is designed for the treatment of medically refractory partial epilepsy and includes implantable and external products. The company was founded by Rebecca L. Kuhn, Frank M. Fischer on November 19, 1997 and is headquartered in Mountain View, CA.
Stock Forecast FAQ
In the current month, NPCE has received 7 Buy ratings 0 Hold ratings, and 0 Sell ratings. The NPCE average analyst price target in the past 3 months is $17.13.
-
Where Will NeuroPace, Inc. Stock Be In 1 Year?
According to analysts, the consensus estimate is that NeuroPace, Inc. share price will rise to $17.13 per share over the next 12 months.
-
What Do Analysts Say About NeuroPace, Inc.?
Analysts are divided on their view about NeuroPace, Inc. share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that NeuroPace, Inc. is a Sell and believe this share price will drop from its current level to $13.00.
-
What Is NeuroPace, Inc.'s Price Target?
The price target for NeuroPace, Inc. over the next 1-year time period is forecast to be $17.13 according to 7 Wall Street analysts, 7 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
-
Is NPCE A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for NeuroPace, Inc. is a Buy. 7 of 7 analysts rate the stock a Buy at this time.
-
How Can I Buy Shares Of NPCE?
You can purchase shares of NeuroPace, Inc. via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase NeuroPace, Inc. shares.
-
What Is The NeuroPace, Inc. Share Price Today?
NeuroPace, Inc. was last trading at $17.01 per share. This represents the most recent stock quote for NeuroPace, Inc.. Yesterday, NeuroPace, Inc. closed at $16.97 per share.
-
How To Buy NeuroPace, Inc. Stock Online?
In order to purchase NeuroPace, Inc. stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
Get NPCE Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
NPCE
Sector
P/E ratio
--
23.66x
PEG ratio
--
-0.01x
P/B ratio
30.52x
1.84x
Price / LTM sales
5.70x
1.60x
Growth Metrics
NPCE
Sector
Revenue growth
29.89%
4.85%
Earnings growth
43.04%
11.15%
Revenue (5-year growth)
16.67%
6.45%
Earnings forecast
-$0.19
-$0.20
Profitability
NPCE
Sector
Profitability FY 2024
$59.1M
$3.6M
Return on invested capital
-27.09%
-30.98%
Return on assets
-23.31%
-27.62%
Return on equity
-149.8%
-36.69%
Earnings Date
Last Earnings Date
Nov
4
Next Earnings Date
Mar
3
Estimated Next Earnings Date
Feb
3
Balance Sheet
NPCE
Sector
Total cash
$60M
$27.2M
Short term investments
$39.3M
$25.7M
Total assets
$94.6M
$79.9M
Long term debt
$69.1M
$4.1M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Google Vs NVIDIA Stock: Which Is Best?
Alphabet (NASDAQ:GOOGL) and NVIDIA (NASDAQ:NVIDIA) are two of the market’s…
How High Could NVIDIA Stock Go?
NVIDIA (NASDAQ:NVDA) has been one of the best stocks to…
Stock Ideas
Buy
52
Is NVDA Stock a Buy?
Market Cap: $4.5T
P/E Ratio: 62x
Buy
61
Is AAPL Stock a Buy?
Market Cap: $4.1T
P/E Ratio: 38x
Buy
63
Is GOOG Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 40x
Alerts
Buy
54
SMX alert for Dec 5
SMX (Security Matters) Plc [SMX] is up 154.74% over the past day.
Sell
15
HOV alert for Dec 5
Hovnanian Enterprises, Inc. [HOV] is down 22.58% over the past day.
Buy
67
NUTX alert for Dec 5
Nutex Health, Inc. [NUTX] is up 18.9% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
